Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations.

A recent literature review highlighted how an active form of vitamin D may help prevent colorectal cancer and improve survival in people with colorectal cancer. The impact of vitamin D has been a ...

“Our results highlight a strong link between statin use and improved survival in this patient population.” CLL is a slow-growing cancer that starts in the blood-forming cells of the bone ...

In 2004, the National Cancer Institute sponsored the Costa Rica HPV vaccine trial that evaluated the safety and efficacy of three doses of Cervarix in nearly 7,500 women ages 18 to 25 compared ...

These findings are important because they help explain how some HPV-related lesions progress to cancer while others heal on their own. High-risk HPV is known to cause several types of anogenital ...

Here’s the bottom line — nearly 53,000 Americans are projected to die from colorectal cancer this year. The overall five-year survival rate for the disease is around 65%. Several factors ...

Patients with a rare and aggressive type of blood cancer could soon have their chances of survival doubled as a groundbreaking trial to detect the disease earlier concludes. Scientists working on ...

Teddi Mellencamp stepped out for her first formal appearance at an event since her cancer diagnosis. At An Unforgettable Evening Benefiting the Women’s Cancer Research Fund in Beverly Hills on ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy, surgery, and radiation for some forms of cancer. Nearly 80% of patients who suffered from ...

A highly sensitive test that detects traces of disease in the bone marrow of patients with a rare and aggressive type of blood cancer could help double their chances of survival, a first-of-its ...

This article provides an overview of developments in advanced prostate cancer and considers how the available options for lengthening survival for men with mCRPC may be sequenced.